Skip to main content
Article thumbnail
Location of Repository

SVOP Is a Nucleotide Binding Protein

By Jia Yao and Sandra M. Bajjalieh
Topics: Research Article
Publisher: Public Library of Science
OAI identifier:
Provided by: PubMed Central

Suggested articles


  1. (1999). Abnormal neurotransmission in mice lacking synaptic vesicle protein 2A (SV2A).
  2. (2008). Anticonvulsive and anti-epileptic properties of brivaracetam (ucb 34714), a highaffinity ligand for the synaptic vesicle protein, SV2A.
  3. (2003). Antihyperalgesic effect of levetiracetam in neuropathic pain models in rats.
  4. (2006). Binding characteristics of levetiracetam to synaptic vesicle protein 2A (SV2A) in human brain and in CHO cells expressing the human recombinant protein.
  5. (1993). Brain contains two forms of synaptic vesicle protein 2.
  6. (1998). Carruthers A
  7. (1977). Cleavage at Asn-Gly bonds with hydroxylamine.
  8. (2008). Effects of levetiracetam on tardive dyskinesia: a randomized, double-blind, placebocontrolled study.
  9. (1988). Endocrine secretory granules and neuronal synaptic vesicles have three integral membrane proteins in common.
  10. (2005). Expression of synaptic vesicle tworelated protein SVOP in the developing nervous system of Xenopus laevis.
  11. (1985). Identification of a transmembrane glycoprotein specific for secretory vesicles of neural and endocrine cells.
  12. (2007). Identification of six putative human transporters with structural similarity to the drug transporter SLC22 family.
  13. (1996). Isoform-specific, calciumregulated interaction of the synaptic vesicle proteins SV2 and synaptotagmin.
  14. (2006). Levetiracetam in tardive dyskinesia.
  15. (1989). Most synaptic vesicles isolated from rat brain carry three membrane proteins, SV2, synaptophysin, and p65.
  16. (2001). SNARE-mediated membrane fusion.
  17. (2006). Specific effect of levetiracetam in experimental human pain models.
  18. (2001). SV2 modulates the size of the readily releasable pool of secretory vesicles.
  19. (1992). SV2, a brain synaptic vesicle protein homologous to bacterial transporters.
  20. (1999). SV2A and SV2B function as redundant Ca2+ regulators in neurotransmitter release.
  21. (2005). SV2A and SV2C contain a unique synaptotagmin-binding site.
  22. (2004). SV2B regulates synaptotagmin 1 by direct interaction.
  23. (1999). SV2C is a synaptic vesicle protein with an unusually restricted localization: Anatomy of a synaptic vesicle protein family.
  24. (1998). SVOP, an evolutionarily conserved synaptic vesicle protein, suggests novel transport functions of synaptic vesicles.
  25. (2008). Synaptic vesicle protein 2 binds adenine nucleotides.
  26. (2006). Synaptic vesicle protein 2 enhances release probability at quiescent synapses.
  27. (1993). The 12-transmembrane helix transporters.
  28. (1989). The human erythrocyte sugar transporter is also a nucleotide binding protein.
  29. (1992). The synaptic vesicle protein SV2 is a novel type of transmembrane transporter.
  30. (2004). The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam.

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.